A short explainer on how tirzepatide works on GIP and GLP-1 receptors, set against drugs that hit three hormone pathways.
Recap by typeshit. Post by @golfmusclemaster on Instagram.
The study of over 87,000 matched patients 65 and up also found 28% fewer liver decompensation events, but no drop in heart attack or stroke and more osteoporosis diagnoses.
18:05
Dr. Stirrett walks through three pointers for people on tirzepatide, framed as part of a broader GLP-1 guide. His advice, not a set protocol.
He walks through an Azoury et al study in the October 2026 Plastic and Reconstructive Surgery that uses global health network data to compare the two weight loss routes.
The claim credits GLP-1 drugs' effects on insulin sensitivity and inflammation for changes in dermatologic conditions. No study is cited.
In a new suit, Frank Campbell Jr. claims he developed gastroparesis after starting the drugs, leaving him with debilitating nausea, vomiting and abdominal pain.
As GLP-1 use keeps climbing, a new worry is getting attention: what the drugs' popularity may be doing to how people see their bodies.
Loading…